Carl Zeiss Meditec AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0005313704
EUR
43.30
0.36 (0.84%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
2,041.70
2,159.45
2,015.10
1,659.33
1,431.72
1,398.44
Shareholder's Funds
2,041.70
2,159.45
2,015.10
1,659.33
1,431.72
1,398.44
Minority Interest
14.78
13.45
14.99
18.06
18.84
18.52
Long-Term Borrowings
502.60
142.03
112.86
95.89
102.67
123.86
Secured Loans
502.60
142.03
112.86
95.89
102.67
123.86
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
52.16
-28.66
-49.37
-69.53
-77.41
-78.20
Other Long Term Liabilities
349.71
202.34
162.23
194.56
179.76
156.56
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
25.75
15.61
15.50
61.87
98.25
87.00
Total Non-Current Liabilities
808.61
298.38
253.41
270.47
266.71
265.57
Current Liabilities
Trade Payables
110.55
157.83
124.39
98.23
55.13
83.45
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
25.75
15.61
15.50
61.87
98.25
87.00
Total Current Liabilities
568.84
561.65
539.32
448.12
297.58
339.60
Total Liabilities
3,433.92
3,032.92
2,822.82
2,395.97
2,014.85
2,022.13
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
615.35
548.16
458.77
379.88
320.31
280.47
Less: Accumulated Depreciation
261.58
232.38
222.63
180.32
185.04
163.72
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
353.76
315.77
236.15
199.56
135.26
116.75
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
35.60
34.59
19.45
15.90
13.33
16.13
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
15.68
31.86
1.19
0.79
3.83
1.48
Total Non-Current Assets
2,221.44
1,121.20
1,030.96
791.95
724.34
717.80
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
536.56
520.23
382.75
286.38
286.36
268.32
Sundry Debtors
209.05
196.92
197.80
185.94
165.16
205.79
Cash and Bank
20.29
10.60
7.73
7.44
6.20
22.64
Other Current Assets
1,139.78
1,827.98
1,756.91
1,588.47
1,272.49
1,291.30
Short Term Loans and Advances
373.88
1,100.24
1,168.63
1,108.71
814.77
794.55
Total Current Assets
1,212.48
1,911.73
1,791.85
1,604.02
1,290.51
1,304.33
Net Current Assets (Including Current Investments)
643.65
1,350.08
1,252.54
1,155.90
992.92
964.73
Total Current Assets Excluding Current Investments
1,212.48
1,911.73
1,791.85
1,604.02
1,290.51
1,304.33
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
3,433.92
3,032.92
2,822.82
2,395.97
2,014.85
2,022.13
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
502.60
142.03
112.86
95.89
102.67
123.86
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Sep 2024 is 377.87% vs 5.32% in Sep 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Sep 2024 is 72.83% vs 24.72% in Sep 2023

stock-summary

Fixed Assets

YoY Growth in year ended Sep 2024 is 12.03% vs 33.72% in Sep 2023

stock-summary

Investments

YoY Growth in year ended Sep 2024 is 2.92% vs 77.84% in Sep 2023

stock-summary

Current Assets

YoY Growth in year ended Sep 2024 is -36.58% vs 6.69% in Sep 2023

Compare Balance Sheet Results of Carl Zeiss Meditec AG
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
2,041.70
19,542.00
-17,500.30
-89.55%
Shareholder's Funds
2,041.70
19,542.00
-17,500.30
-89.55%
Minority Interest
14.78
748.00
-733.22
-98.02%
Long-Term Borrowings
502.60
12,249.00
-11,746.40
-95.90%
Secured Loans
502.60
12,249.00
-11,746.40
-95.90%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
52.16
216.00
-163.84
-75.85%
Other Long Term Liabilities
349.71
4,774.00
-4,424.29
-92.67%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
25.75
1,322.00
-1,296.25
-98.05%
Total Non-Current Liabilities
808.61
14,251.00
-13,442.39
-94.33%
Current Liabilities
Trade Payables
110.55
1,359.00
-1,248.45
-91.87%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
25.75
1,322.00
-1,296.25
-98.05%
Total Current Liabilities
568.84
9,009.00
-8,440.16
-93.69%
Total Liabilities
3,433.92
43,550.00
-40,116.08
-92.11%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
615.35
15,886.00
-15,270.65
-96.13%
Less: Accumulated Depreciation
261.58
5,996.00
-5,734.42
-95.64%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
353.76
9,890.00
-9,536.24
-96.42%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
35.60
3,940.00
-3,904.40
-99.10%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
15.68
320.00
-304.32
-95.10%
Total Non-Current Assets
2,221.44
32,104.00
-29,882.56
-93.08%
Current Assets Loans & Advances
Current Investments
0
0
0.00
0.00%
Inventories
536.56
2,573.00
-2,036.44
-79.15%
Sundry Debtors
209.05
3,678.00
-3,468.95
-94.32%
Cash and Bank
20.29
2,282.00
-2,261.71
-99.11%
Other Current Assets
1,139.78
10,368.00
-9,228.22
-89.01%
Short Term Loans and Advances
373.88
1,835.00
-1,461.12
-79.63%
Total Current Assets
1,212.48
11,446.00
-10,233.52
-89.41%
Net Current Assets (Including Current Investments)
643.65
2,437.00
-1,793.35
-73.59%
Total Current Assets Excluding Current Investments
1,212.48
11,446.00
-10,233.52
-89.41%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
3,433.92
43,550.00
-40,116.08
-92.11%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
502.60
12,249.00
-11,746.40
-95.90%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 458.90 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 377.87% vs 5.32% in Sep 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 349.71 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 72.83% vs 24.72% in Sep 2023

Annual - Fixed Assets
Fixed Assets 353.76 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 12.03% vs 33.72% in Sep 2023

Annual - Investments
Investments 35.60 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 2.92% vs 77.84% in Sep 2023

Annual - Current Assets
Current Assets 1,212.48 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is -36.58% vs 6.69% in Sep 2023